GB Sciences, Inc. (GBLX)
OTCMKTS
· Delayed Price · Currency is USD
0.0009
+0.0001 (12.50%)
Mar 14, 2025, 4:00 PM EST
GB Sciences Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Selling, General & Admin | 0.75 | 1.16 | 1.18 | 1.05 | 1.65 | 5.74 | Upgrade
|
| Research & Development | 0.26 | 0.26 | 0.49 | 0.82 | 0.35 | - | Upgrade
|
| Operating Expenses | 1.02 | 1.42 | 1.67 | 1.87 | 2 | 5.74 | Upgrade
|
| Operating Income | -1.02 | -1.42 | -1.67 | -1.87 | -2 | -5.74 | Upgrade
|
| Interest Expense | -0.2 | -0.22 | -0.18 | -0.47 | -1.29 | -1.11 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.1 | 0.01 | -0.65 | -0.18 | Upgrade
|
| EBT Excluding Unusual Items | -1.21 | -1.64 | -1.75 | -2.33 | -3.94 | -7.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 5.19 | - | 4.39 | Upgrade
|
| Asset Writedown | -0 | -0.04 | -2.37 | - | - | - | Upgrade
|
| Other Unusual Items | 0.09 | 0.32 | - | -3 | 0.6 | -2.11 | Upgrade
|
| Pretax Income | -1.13 | -1.36 | -4.13 | -0.15 | -3.33 | -4.75 | Upgrade
|
| Earnings From Continuing Operations | -1.13 | -1.36 | -4.13 | -0.15 | -3.33 | -4.75 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.38 | -0.39 | -8.36 | Upgrade
|
| Net Income to Company | -1.13 | -1.36 | -4.13 | -0.53 | -3.73 | -13.11 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 0.74 | Upgrade
|
| Net Income | -1.13 | -1.36 | -4.13 | -0.53 | -3.73 | -12.37 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.01 | 0.28 | - | - | - | - | Upgrade
|
| Net Income to Common | -1.14 | -1.64 | -4.13 | -0.53 | -3.73 | -12.37 | Upgrade
|
| Shares Outstanding (Basic) | 406 | 397 | 358 | 318 | 285 | 258 | Upgrade
|
| Shares Outstanding (Diluted) | 406 | 397 | 358 | 318 | 285 | 258 | Upgrade
|
| Shares Change (YoY) | 5.59% | 10.90% | 12.62% | 11.37% | 10.35% | 23.34% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | -0.05 | Upgrade
|
| Free Cash Flow | -0.59 | -0.98 | -1.53 | -1.87 | -2.19 | -4.48 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 | Upgrade
|
| EBITDA | -1.02 | -1.42 | -1.61 | -1.8 | -1.95 | -5.62 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.06 | 0.07 | 0.05 | 0.13 | Upgrade
|
| EBIT | -1.02 | -1.42 | -1.67 | -1.87 | -2 | -5.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.